Related Experiment Video
Updated: Feb 26, 2026

Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells
Walaa Eid1,2, Kristin Dauner3, Kevin C Courtney1
1Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada K1H 8L6.
Abstract:
mTORC1 is known to activate sterol regulatory element-binding proteins (SREBPs) including SREBP-2, a master regulator of cholesterol synthesis. Through incompletely understood mechanisms, activated mTORC1 triggers translocation of SREBP-2, an endoplasmic reticulum (ER) resident protein, to the Golgi where SREBP-2 is cleaved to translocate to the nucleus and activate gene expression for cholesterol synthesis. Low ER cholesterol is a well-established trigger for SREBP-2 activation. We thus investigated whether mTORC1 activates SREBP-2 by reducing cholesterol delivery to the ER. We report here that mTORC1 activation is accompanied by low ER cholesterol and an increase of SREBP-2 activation. Conversely, a decrease in mTORC1 activity coincides with a rise in ER cholesterol and a decrease in SERBP-2 activity. This rise in ER cholesterol is of lysosomal origin: blocking the exit of cholesterol from lysosomes by U18666A or NPC1 siRNA prevents ER cholesterol from increasing and, consequently, SREBP-2 is activated without mTORC1 activation. Furthermore, when mTORC1 activity is low, cholesterol is delivered to lysosomes through two membrane trafficking pathways: autophagy and rerouting of endosomes to lysosomes. Indeed, with dual blockade of both pathways by Atg5-/- and dominant-negative rab5, ER cholesterol fails to increase when mTORC1 activity is low, and SREBP-2 is activated. Conversely, overexpressing constitutively active Atg7, which forces autophagy and raises ER cholesterol even when mTORC1 activity is high, suppresses SREBP-2 activation. We conclude that mTORC1 actively suppresses autophagy and maintains endosomal recycling, thereby preventing endosomes and autophagosomes from reaching lysosomes. This results in a reduction of cholesterol in the ER and activation of SREBP-2.
Insights
Mammalian target of rapamycin complex 1 (mTORC1) activates SREBP-2, a cholesterol synthesis regulator, by suppressing autophagy and endosomal recycling. This mechanism lowers ER cholesterol, thereby activating SREBP-2.
Area of Science:
- Cellular biology
- Molecular mechanisms of cholesterol homeostasis
Background:
- Mammalian target of rapamycin complex 1 (mTORC1) activates sterol regulatory element-binding proteins (SREBPs), key regulators of cholesterol synthesis.
- Activated SREBP-2 translocates to the nucleus to promote cholesterol synthesis gene expression.
- Low endoplasmic reticulum (ER) cholesterol is a known trigger for SREBP-2 activation.
Purpose of the Study:
- To investigate the mechanism by which mTORC1 activates SREBP-2, specifically examining its role in cholesterol delivery to the ER.
- To determine if mTORC1 influences SREBP-2 activation by modulating cholesterol transport pathways.
Main Methods:
- Investigated the relationship between mTORC1 activity, ER cholesterol levels, and SREBP-2 activation.
- Utilized pharmacological inhibitors (U18666A) and genetic manipulation (NPC1 siRNA, Atg5-/-, dominant-negative rab5, Atg7 overexpression) to disrupt lysosomal cholesterol export and membrane trafficking pathways.
- Assessed the impact of these manipulations on ER cholesterol levels and SREBP-2 activation.
Main Results:
- mTORC1 activation correlated with decreased ER cholesterol and increased SREBP-2 activation.
- Inhibition of cholesterol exit from lysosomes led to SREBP-2 activation independently of mTORC1.
- Blocking autophagy and endosomal recycling to lysosomes caused SREBP-2 activation when mTORC1 activity was low.
- Forced autophagy elevated ER cholesterol and suppressed SREBP-2 activation, even with high mTORC1 activity.
Conclusions:
- mTORC1 suppresses autophagy and promotes endosomal recycling, preventing cholesterol-laden endosomes and autophagosomes from reaching lysosomes.
- This suppression of lysosomal cholesterol delivery leads to reduced ER cholesterol levels.
- The resulting low ER cholesterol activates SREBP-2, thereby promoting cholesterol synthesis.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Catabolism
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

